Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study
European Journal of Internal Medicine Jan 08, 2020
Rodríguez-Ortiza ME, Alcalá-Díazb JF, Canalejo A, et al. - In this cross-sectional study, researchers involved 939 individuals with coronary heart disease recorded in the CORDIOPREV study in which intima-media thickness of both common carotid arteries (IMT-CC) was measured, in order to examine the correlations among fibroblast growth factor 23 (FGF23, a major determinant of mineral metabolism derangements which emerged as a potential risk factor underlying the negative cardiovascular outcome in individuals with CKD) and mineral metabolism parameters and with carotid atherosclerosis in a population at great cardiovascular risk with preserved renal function. It was found that FGF23 freely correlated with IMT-CC, a surrogate of atherosclerotic vascular dysfunction, even in the setting of a normally functioning phosphate-FGF23-calcitriol system, hence supporting the fact of FGF23 being a predictor of cardiovascular risk-free of renal failure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries